OBJECTIVE: The vesicular and soluble components of cell-free products must be comprehensively characterized to unravel potential therapeutic targets. In this context, we characterized ASC-conditioned medium (CM) and tested its effects in counteracting osteoarthritis (OA) drawbacks. MATERIALS and METHODS: CM was obtained from human primary ASCs maintained in serum-free medium for 72h. After concentration, the content was analysed using biochemical, spectroscopical and omics approaches. NTA and TEM gave a punctual description of its vesicular fraction. In vitro effects were measured in three OA models: 2D-chondrocytes, ex-vivo punches of exfoliated cartilage and osteochondral explants, all stimulated with inflammatory cytokines. In addition, CM chemotactic properties were also assessed. RESULTS: CM characterization emphasised a high EVs content, confirming the preservation after the concentration process, as well as a multitude of soluble factors. Several of these bioactive molecules were positively associated with anti-catabolic and immunomodulatory pathways. These findings were confirmed through the significative reduction of MMP activity in the different OA models, and the chemotactic action on THP-1 cells. DISCUSSION: The wide range characterization of the CM highlighted its rich composition of soluble and EV-embedded effectors, including proteins and bioactive lipids, suggesting its potential use in the context of OA and, eventually, other inflammatory pathologies.

Conditioned medium produced by mesenchymal stromal cells against joint disorders: content characterization and effects in increasingly complex models of osteoarthritis / F. Cadelano, C. Giannasi, S. Niada, E. Della Morte, A. Brini. ((Intervento presentato al convegno Translating EVs from the bench to the bedside tenutosi a Padova nel 2024.

Conditioned medium produced by mesenchymal stromal cells against joint disorders: content characterization and effects in increasingly complex models of osteoarthritis

F. Cadelano
Primo
;
C. Giannasi
Secondo
;
S. Niada;A. Brini
Ultimo
2024

Abstract

OBJECTIVE: The vesicular and soluble components of cell-free products must be comprehensively characterized to unravel potential therapeutic targets. In this context, we characterized ASC-conditioned medium (CM) and tested its effects in counteracting osteoarthritis (OA) drawbacks. MATERIALS and METHODS: CM was obtained from human primary ASCs maintained in serum-free medium for 72h. After concentration, the content was analysed using biochemical, spectroscopical and omics approaches. NTA and TEM gave a punctual description of its vesicular fraction. In vitro effects were measured in three OA models: 2D-chondrocytes, ex-vivo punches of exfoliated cartilage and osteochondral explants, all stimulated with inflammatory cytokines. In addition, CM chemotactic properties were also assessed. RESULTS: CM characterization emphasised a high EVs content, confirming the preservation after the concentration process, as well as a multitude of soluble factors. Several of these bioactive molecules were positively associated with anti-catabolic and immunomodulatory pathways. These findings were confirmed through the significative reduction of MMP activity in the different OA models, and the chemotactic action on THP-1 cells. DISCUSSION: The wide range characterization of the CM highlighted its rich composition of soluble and EV-embedded effectors, including proteins and bioactive lipids, suggesting its potential use in the context of OA and, eventually, other inflammatory pathologies.
13-mar-2024
Settore BIO/14 - Farmacologia
Conditioned medium produced by mesenchymal stromal cells against joint disorders: content characterization and effects in increasingly complex models of osteoarthritis / F. Cadelano, C. Giannasi, S. Niada, E. Della Morte, A. Brini. ((Intervento presentato al convegno Translating EVs from the bench to the bedside tenutosi a Padova nel 2024.
Conference Object
File in questo prodotto:
File Dimensione Formato  
Francesca_Cadelano_Abstract_Padova.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 62.69 kB
Formato Adobe PDF
62.69 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1041770
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact